PL88891B1 - - Google Patents
Download PDFInfo
- Publication number
- PL88891B1 PL88891B1 PL14409270A PL14409270A PL88891B1 PL 88891 B1 PL88891 B1 PL 88891B1 PL 14409270 A PL14409270 A PL 14409270A PL 14409270 A PL14409270 A PL 14409270A PL 88891 B1 PL88891 B1 PL 88891B1
- Authority
- PL
- Poland
- Prior art keywords
- glycerin
- aluminum hydroxide
- soap
- perspirant
- hexachlorophene
- Prior art date
Links
- 239000000344 soap Substances 0.000 claims description 8
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 7
- 230000001166 anti-perspirative effect Effects 0.000 claims description 7
- 239000003213 antiperspirant Substances 0.000 claims description 7
- 229960004068 hexachlorophene Drugs 0.000 claims description 7
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 239000002826 coolant Substances 0.000 claims description 3
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 3
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- -1 aluminum compound Chemical class 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 206010027654 Allergic conditions Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010051602 Laziness Diseases 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Description
Przedmiotem wynalazku jest srodek przeciwko poceniu. Dotychczas stosowane na swiecie srodki przeciwfpotowe sa to ba&z doprowadzone do odpo¬ wiedniej konsystencji zwiazki glinu w postaci ze¬ lu, stopy mydel gliceryno-rycyno-tluszczowych lub syntetyczne wieloczasteczkowe podloza. W tych podlozach znajduja sie- srodki farmakologiczne o dzialaniu adsorbujacym, dezynfekcyjnym, sciaga¬ jacym, przeciwgnilnym, ograniczajacym wydziela¬ nie potu i temu podobne, jak wodorotlenek glinu, heksachlorofen, tetramina, chlorofil. Prawie wszy¬ stkie te srodki nie sa obojetne dla normalnego funkcjonowania skóry i znajdujacych sie w niej gruczolów potowych. Moga one powodowac zam¬ kniecie ujscia gruczolu potowego, bardzo niebez¬ pieczne, nacieki zapalne z limfocytoza, swiad i zwyrodnienie czesci wydzielniczej (klejbka) gruczo¬ lu potowego, czop rogowy, nakrozy skórne, zapa¬ lenie i stany alergiczne.The subject of the invention is a remedy against sweating. Means used so far in the world antiperspirant are also restored aluminum compound in the form of a bad consistency lu, glycerin-ricin-fatty soaps or synthetic multi-molecular substrate. In these in the substrates there are pharmacological agents about adsorbing, disinfecting and pulling action foul, anti-rot, limiting secretion no sweat and the like, like aluminum hydroxide, hexachlorophene, tetramine, chlorophyll. Almost everything These measures are not indifferent to the normal the functioning of the skin and in it sweat glands. They can cause stuttering ridge at the mouth of the sweat gland, very dangerous painful, inflammatory infiltrates with lymphocytosis, itching and degeneration of the secretory part of the gland sweat, horny plug, skin spots, inflammation laziness and allergic conditions.
Preparaty te z punktu widzenia zdrowotnego nie powinny byc stosowane zibyt czesto, co nawet nie¬ które firmy produkujace same zaznaczaja. Poza tym srodki produkowane w kraju odznaczaja sie nietrwaloscia srodków farmakologicznych oraz ten¬ dencja do wysychania i zmiany konsystencji. Nie¬ którzy producenci, chroniac preparat przed wy¬ schnieciem, oblewafja go parafina lub inna substan¬ cja chroniaca przed wysychaniem, co jest bardzo niewygodne w uzyciu. - 20 ¦i Celem wynalazku jest wyeliminowanie dotych ^czasowych wad srodków przeciwko poceniu przy "zachowaniu wszelkich wlasnosci farmakologicznych.These preparations, from a health point of view, are not should be used too often, even if not which producing companies mark themselves. Pose this is what the means produced in the country are distinguished by instability of pharmacological agents and ten a tendency to dry out and change consistency. No which manufacturers, to protect the preparation from breakdown drying, it is coated with paraffin or other substance prevents drying out, which is very inconvenient to use. - twenty The object of the invention is to eliminate the above ^ temporary disadvantages of anti-perspirants at "preservation of all pharmacological properties.
Cel ten zostal osiagniety przez opracowanie srod¬ ka przeciwko poceniu, który zawiera 0,5—3°/o hek- sametylenotetraminy, 0,5—3% heksachlorofenu, 0,5—3% znanych srodków zapachowych, chlodza¬ cych i barwiacych, 10—15% wodorotlenku glinu, a ponadto zawiera 1,5—3% witaminy F oraz mydlo glicerynowo^stearynowe w ilosci, uzupelniajacej sklad do 100%.This goal was achieved by developing a measure anti-perspirant, which contains 0.5-3% per hek- samethylenetetramine, 0.5-3% hexachlorophene, 0.5-3% of known fragrances, cool and dyes, 10-15% aluminum hydroxide, a in addition, it contains 1.5-3% of vitamin F and soap glycerin ^ stearin in a supplemental amount composition up to 100%.
W srodku wedlug wynalazku wyeliminowano ze Srodka przeciw poceniu wode, a zastapiono ja my¬ dlem glicerynowo-stearynowym w ilosci, dopelnia¬ jacej mieszanine do 100%. Adsorbentem jest wo¬ dorotlenek glinu w ilosci 10—15%, a srodkiem o- chronnym witamina F w ilosci 1,5—3%. Reszta to znane i stosowane srodki bakteriobójcze, grzybo- Jbójcze, sciagajace i dodatki srodków zapachowych, chlodzacych, barwiacych, poprawiajacych wyglad, zapach srodka i zapewniajace komfort uzycia.In the center, according to the invention, it is eliminated The anti-perspirant was water, and it was replaced with a wash with glycerin-stearin in the amount, fill in mix up to 100%. The adsorbent is water aluminum hydroxide in the amount of 10-15%, and the agent with vitamin F in the amount of 1.5-3%. The rest is known and used bactericides, fungus Killer, astringent and aromatic additives, cooling, coloring, improving the appearance, fragrance and the comfort of use.
W/w mieszanina jest farmakologicznie nieczynna.The above-mentioned mixture is pharmacologically inactive.
Zawarte w niej srodki dzialaja dopiero w zet¬ knieciu z wydzielina potowa, a sila dzialania jest wprost proporcjonalna do ilosci wydzielanego po¬ tu. Ponizej podano przyklady receptury srodka wedlug wynalazku, w którym zawartosci poszcze¬ gólnych skladników sa wyrazone w czesciach wa¬ gowych. / 88 891 \mmi 3 Przyklad I.The funds contained therein only become effective the prick of sweat secretion, and the force of action is directly proportional to the amount of discharged here. Formulation examples are given below according to the invention, in which the contents of the individual major components are expressed in parts of the shaft head. / 88 891 \ mmi 3 Example I.
Mydlo glicerynowo-stearynowe Heksametylenotetramina Heksachlorofen Wodorotlenek glinu Witamina F Mentol Olejek Lawendowy Chlorofil 82 1,00 1,00 ,00 3,00 1,5 1,0 Przyklad II.Glycerin-stearic soap Hexamethylenetetramine Hexachlorophene Aluminum hydroxide Vitamin F. Menthol Lavender oil Chlorophyll 82 1.00 1.00 , 00 3.00 1.5 1.0 Example II.
Mydlo glicerynowo-stearynowe 81 Heksametylenotetramina 0,7^ Heksachlorofen 0,75 Wodorotlenek glinu (alusal) 12,0 WitaminaF 2;5 Mentol 1,5 Olejekrózany 1,5 Optymalny sklad srodka przeciwko poceniu sta¬ nowi 0,75% heksaimetylenotetraminy, 0,75% heksa- chlorofenu, 3% srodków zapachowych, barwiacych i chlodzacych oraz 10% wodorotlenku glinu, 2,5% witaminy F i 83% mydla* glicerynowo-stearyno- Sposób wytwarzania srodka przeciwko poceniu wedlug wynalazku polega na tym, ze w I fazie otrzymuje sie w znany sposób mydlo glicerynowo- -stearynowe w ten sposób, ze w kotle emaliowa¬ nym, zaopatrzonym w mieszadlo wolnoobrotowe, ogrzewa sie gliceryne w tamperajlirzje o3il0O?C2 otao- lo 0,5 godziny, nastepnie rozpuszcza aie^w. niej bez¬ wodny weglan sodu i dodaje s^e mftfyjrn? porcjami rozdrobniony kwas stearynowy.Mieszanine te ogrze¬ wa, sie ca 0,5 godziny, stale mieszajac. Dla ulat¬ wienia moizna dodac srodka przeciw pienieniu sie.Glycerin-stearic soap 81 Hexamethylenetetramine 0.7 ° C Hexachlorophene 0.75 Aluminum hydroxide (alusal) 12.0 VitaminF 2; 5 Menthol 1.5 Rose oil 1.5 Optimal composition of the solid anti-perspirant new 0.75% hexaimethylene tetramine, 0.75% hexa chlorophene, 3% perfumes, coloring agents and cooling agents and 10% aluminum hydroxide, 2.5% vitamins F and 83% soap * glycerin-stearin- A method of producing an anti-perspirant according to the invention it consists in the first phase is obtained in the known manner glycerine soap - stearic in such a way that enamel in the kettle equipped with a low-speed agitator, is heated with glycerin in tamperajlirzje o3il0O? C2 otao- for 0.5 hours, then it dissolves the aids. her without aqueous sodium carbonate, and added? portions crushed stearic acid. Heat the mixture it takes about 0.5 hours, stirring constantly. For the fugitives antifoam can be added to the base.
Jezeli pobrana próbka powstalego my,d$&; rozpusz¬ cza sie w wodzie, oznacza to koiuset D&aifccji zmy- djania. Po otrzymaniu mydla jatoj j^radftiktu wyj¬ sciowego przystepuje sie do wprowwtonia srod¬ ków farmakologicznyeh i uzupelniajacych. W tym celu do plynnej masy otrzymanego uprzednio my¬ dla wprowadza sie heksaimetylenotetramine, heksa¬ chlorofen, wodorotlenek glinu, a pjfi) ostudzeniu do temperatury ca 45°C dodajemy witamine% F i olej¬ ki zapachowe, srodki chlodzac i barwifceg. Mie¬ szanine wylewa sie do form. Gotowa masa ma nastepujace wlasnosci: C. wl. 2,25-£, pH=6,8—7.If the resulting sample is taken, d $ &; dissolve lingers in water, this means a set of senses djania. After receiving the soap, it was taken out of the maternity assistant is proceeding to wprowwtonia Wednesday pharmacological and complementary treatments. Including aim to the liquid mass obtained previously for introducing hexaimethylene tetramine, hexa chlorophene, aluminum hydroxide, and pjfi) cooled down to temperature of about 45 ° C, we add vitamin% F and oil fragrances, cooling agents and dyes. Have Shanine is poured out into forms. The finished mass has the following properties: C. wl. 2.25- £, pH = 6.8-7.
Jest to szklista jednolita masa silnie higroskopijna.It is a glassy uniform mass, highly hygroscopic.
? Bltk 2121/76 r. 105 egz. A4 Cena 10 zl i? Bltk 2121/76. 105 copies A4 Price: PLN 10 and
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL14409270A PL88891B1 (en) | 1970-10-28 | 1970-10-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL14409270A PL88891B1 (en) | 1970-10-28 | 1970-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL88891B1 true PL88891B1 (en) | 1976-10-30 |
Family
ID=19952634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14409270A PL88891B1 (en) | 1970-10-28 | 1970-10-28 |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL88891B1 (en) |
-
1970
- 1970-10-28 PL PL14409270A patent/PL88891B1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4702916A (en) | Analgesic stick compositions | |
| US4049792A (en) | Antiperspirant stick | |
| US4664909A (en) | Stable suspension of powder in alcoholic media | |
| EP0135315B2 (en) | Antiperspirant creams | |
| DE2752420A1 (en) | ANTI-TRANSPIRANE PREPARATION | |
| WO1997002025A1 (en) | Antibacterial/bactericidal/antiseptic agent, dermatologic preparation, and detergent composition | |
| US4252789A (en) | Deodorant stick | |
| PL188761B1 (en) | Antiperspirant or deodorising composition | |
| US4832945A (en) | Deodorant stick | |
| US4923478A (en) | Cosmetic stick composition | |
| JPH0618768B2 (en) | Solid powder cosmetics | |
| PL88891B1 (en) | ||
| US4159318A (en) | Oil-free liquid medicated makeup | |
| JPS6075406A (en) | Powdery solid cosmetic | |
| JPS635009B2 (en) | ||
| JP3229570B2 (en) | Bath composition | |
| JP3660537B2 (en) | Powder cosmetics | |
| JPS58128310A (en) | Skin conditioner | |
| JP2829395B2 (en) | Bath composition | |
| CA2343891A1 (en) | Cosmetic compositions containing higher alkyl acetates as emollients | |
| JP2001199841A (en) | Emulsified composition for lipstick | |
| JP3340943B2 (en) | Bath composition | |
| JP3568603B2 (en) | Bath composition | |
| JP2000086445A (en) | Oily cosmetic | |
| JPH0784376B2 (en) | Cosmetics |